CDC

CDC: Every state has an obesity problem

The latest data shows an overall widening of the US.

Endorsement could boost Pfizer vax

Endorsement could boost Pfizer vax

By

It could also eat into Merck's Pneumovax sales.

Patients paying more for diabetes medications

Patients paying more for diabetes medications

By

Yale researchers find patients are paying more money for newer diabetes medications as they gravitate towards insulin analogs, over human synthetic and animal insulin.

Study finds delaying vaccines is risky

Study finds delaying vaccines is risky

By

A study shows that veering off the recommended vaccination schedule ups the risk for childhood seizures.

Medicare to cover some hep. C screening

Patients have to be high-risk or Baby Boomers for coverage.

CDC: un-vaccinated behind measles outbreak

The CDC said Thursday that most of the 288 recent US measles cases were caused by un-vaccinated travelers who brought the virus home with them.

Doctors say vaccines don't pay

Ten percent of surveyed doctors told the Centers for Disease Control that reimbursement rates are not enough.

Merck sends HPV vax to FDA

Merck sends HPV vax to FDA

By

The drugmaker's new vaccine has more brawn, but vaccination rates among boys and girls remain low.

Shutdown created CDC blind spot

The government shutdown resulted in more than 16 million unread CDC emails—the government agency's ability to track illnesses has had a sharp setback.

Shutdown dims lights at FDA, NIH and CDC

Shutdown dims lights at FDA, NIH and CDC

By

The midnight shutdown put 800,000 government employees on leave, including those at the FDA, NIH and CDC.

Kleenex brand goes flu hunting

Kleenex brand goes flu hunting

By

The Kimberly-Clark-backed cold and flu predictor mixes Big Data, and big branding, with an individualized focus.

Business briefs: Biogen, Celgene, J&J, plus Obamacare TV push

Biogen extend Isis relationship for six years and $100M; HHS readies healthcare reform TV push; Medivir ends hep. B clinical trial; FDA approves Celgene cancer drug; Baxter seeks Enbrel biosimilar

Business briefs: CDC, Facebook, Shire

CDC finds that non-Medicare adults make up the majority of preventable heart attack and stroke cases; a Facebook study shows groups can influence HIV screening; and a Shire ADHD drug gets a "no" from Germany

GSK clears another flu vaccine, but patients may not be buying

GSK clears another flu vaccine, but patients may not be buying

By

The FDA approved GlaxoSmithKline's second quadrivalent flu vaccine, but a CVS study indicates that consumers are big fans of the vaccination, as long as they aren't the ones rolling up their sleeves.

HIV messaging goes communal

HIV messaging goes communal

By

Messaging around HIV testing now mixes individual concerns with community protection. Recent efforts, like those of the CDC and Greater than AIDS, try to make getting tested an empowering act.

Business briefs: Astellas, ADA, AJMC, AARP

Astellas teams up with Cytokinetics for muscle weakness research; ADA says lifestyle changes don't protect diabetics' hearts; AJMC talks pharmacists as diabetes counselors; and AARP helps with healthcare reform education.

Business briefs: Gilead, Xarelto

Gilead combo drug clears HCV; FDA denies Xarelto expanded indication for a second time

CDC talks stroke, heart-attack prevention in Spanish

CDC talks stroke, heart-attack prevention in Spanish

By

The Million Hearts initiative just got a Spanish-language rollout, and the culturally sensitive content is starting to gain attention.

Business news: Elsevier, FDA

Elsevier launches a new title, FDA is holding a public hearing on opioids and chronic pain.

Egg-free, mercury-free flu vaccine approved

By

The FDA approved a flu vaccine that can be produced quickly, and lacks many elements that make patients skittish.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.